bibliographicCitation |
Klyuchnikov E, Kröger N, Brummendorf TH, Wiedemann B, Zander AR, Bacher U. Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML). Biol Blood Marrow Transplant. 2010 Mar;16(3):301–10. doi: 10.1016/j.bbmt.2009.08.019. PMID: 19744571. |